StemCell Therapy

Hair StemCell Transplantation - Donor-Regrowth - Day-7 - Part-2
This video shows the donor area 7 days after Hair Stem Cells Transplantation (HST) extractions. The motion of the video-microscope starts from LEFT ear, up and down towards the occiput. SEE ALSO PART 1 !!From:146909Views:0 0ratingsTime:12:59More inScience Technology

Read the rest here:
Hair StemCell Transplantation - Donor-Regrowth - Day-7 - Part-2 - Video

Stem Cells and Ethics
Quarter 2 mini project for Science and Society.From:syates941Views:0 0ratingsTime:06:13More inEducation

Original post:
Stem Cells and Ethics - Video

[BIOS 332] DNA Groups and Stem Cells - Jason Tresser
BIOS 332: Genetics DNA Groups and Stem Cells September 10, 2012From:BiolaUniversityViews:3 0ratingsTime:49:41More inEducation

Link:
[BIOS 332] DNA Groups and Stem Cells - Jason Tresser - Video

Michael Zdanowski of National Cord Blood on public banking - at World Cord Blood Congress 2012
Michael Zdanowski, Director of Operations at National Cord Blood, spoke at the World Cord Blood Congress 2012 on the topic, #39;Self-sustainability for public banking: short and long term perspectives. #39; World Cord Blood Congress is where private and public cord blood banks, pharma and biotechs, academia and government come to debate advances in cord blood banking and therapeutics. For more information, go to http://www.terrapinn.com/cordblood. Or, check out our blog at blogs.terrapinn.com/total-biopharma for up to date information on the stem cells, RM and cord blood banking and therapeutics sectors.From:biopharmachannelViews:0 0ratingsTime:25:08More inScience Technology

Here is the original post:
Michael Zdanowski of National Cord Blood on public banking - at World Cord Blood Congress 2012 - Video

Using Stem Cells to Study Autism
(Visit: http://www.uctv.tv Dr. Dolmetsch #39;s group has developed methods for using induced pluripotent stem cells to study human brain development and for identifying cell and molecular phenotypes associated with disease. His laboratory has also made significant contributions to calcium signaling including the identification of signaling pathways that connect calcium channels to gene activation and the identification of the mechanisms of activation of store operated calcium channels. The lab has also developed several new technologies to study cell signaling including enzyme complementation systems to measure protein interactions in cells and light-activated signaling proteins to control biochemical cascades. Series: "MIND Institute Lecture Series on Neurodevelopmental Disorders" [Health and Medicine] [Show ID: 24425]From:UCtelevisionViews:22 5ratingsTime:01:12:41More inEducation

More here:
Using Stem Cells to Study Autism - Video

"Neural Stem Cells for Severe Spinal Cord Injury" - Dr. Mark Tuszynski
Dr. Tuszynski discusses the findings reported in the journal "Cell" that showed extensive growth of axons in spinal cord injury using grafts of early stage neural stem cells.From:unite2fightparalysisViews:0 0ratingsTime:33:47More inNonprofits Activism

Go here to read the rest:
"Neural Stem Cells for Severe Spinal Cord Injury" - Dr. Mark Tuszynski - Video

What are, and how we use, Stem Cells Spanish on Vimeo
From:Ederson VPViews:0 0ratingsTime:02:16More inPeople Blogs

Read the rest here:
What are, and how we use, Stem Cells Spanish on Vimeo - Video

Safe freezing of stem cells
Copenhagen University Hospital and Pharmacosmos have joined forces to improve current stem cell and tissue freezing methods. The project, Cryodex, has received support from the Danish National Advanced Technology Foundation.From:PharmacosmosViews:1 0ratingsTime:01:26More inScience Technology

Originally posted here:
Safe freezing of stem cells - Video

Greg Bonfiglio of Proteus Venture Partners on cord blood banking - at World Cord Blood Congress 2012
Greg Bonfiglio, Managing Partner of Proteus Venture Partners, spoke at the World Cord Blood Congress 2012 on the topic, #39;Cord blood banking and therapeutics: a perspective on the market. #39; World Cord Blood Congress is where private and public cord blood banks, pharma and biotechs, academia and government come to debate advances in cord blood banking and therapeutics. For more information, go to http://www.terrapinn.com/cordblood. Or, check out our blog at blogs.terrapinn.com/total-biopharma for up to date information on the stem cells, RM and cord blood banking and therapeutics sectors.From:biopharmachannelViews:0 0ratingsTime:21:27More inScience Technology

See the original post:
Greg Bonfiglio of Proteus Venture Partners on cord blood banking - at World Cord Blood Congress 2012 - Video

Jonas Wang of StemCyte on joint public and private banking - at World Cord Blood Congress 2012
Jonas Wang, Chief Executive Officer of StemCyte, spoke at the World Cord Blood Congress 2012 on the topic, #39;Cutting costs with joint public and private banking. #39; World Cord Blood Congress is where private and public cord blood banks, pharma and biotechs, academia and government come to debate advances in cord blood banking and therapeutics. For more information, go to http://www.terrapinn.com/cordblood. Or, check out our blog at blogs.terrapinn.com/total-biopharma for up to date information on the stem cells, RM and cord blood banking and therapeutics sectors.From:biopharmachannelViews:0 0ratingsTime:25:55More inScience Technology

Read the rest here:
Jonas Wang of StemCyte on joint public and private banking - at World Cord Blood Congress 2012 - Video

Hair StemCell Transplantation - Donor-Regrowth - Day-7 - Part-1
This video shows the donor area 7 days after Hair Stem Cells Transplantation (HST) extractions. The motion of the video-microscope starts from the RIGHT ear, up and down towards the occiput. SEE ALSO PART 2 !!From:146909Views:14 0ratingsTime:09:33More inScience Technology

Read more here:
Hair StemCell Transplantation - Donor-Regrowth - Day-7 - Part-1 - Video

SCMU -promotion video
stem cells #39; scientific club - Mansoura UniversityFrom:ali mowafyViews:0 0ratingsTime:02:19More inFilm Animation

See the original post:
SCMU -promotion video - Video

William Prather of Pluristem on treating Aplastic Anemia with stem cells - at Stem Cells USA 2012
William Prather, Sr. VP Corporate Development at Pluristem, spoke at the Stem Cells USA Regenerative Medicine Congress 2012 on the topic, #39;Treating Aplastic Anemia with PLX Stem Cells. #39; The Stem Cells Regenerative Medicine Congress is where pharma, biotech, academia, government and investors come to uncover the technologies, strategies and business models that will help get stem cell and regenerative medicine treatments to market faster and more cost effectively. For more information, go to http://www.terrapinn.com/stemcellsusa. Or, check out our blog at blogs.terrapinn.com/total-biopharma for up to date information on the stem cells, RM and cord blood banking and therapeutics sectors.From:biopharmachannelViews:0 0ratingsTime:21:02More inScience Technology

Continued here:
William Prather of Pluristem on treating Aplastic Anemia with stem cells - at Stem Cells USA 2012 - Video

Edward Lanphier of Sangamo on engineering genetic cures - at Stem Cells USA RM Congress 2012
Edward Lanphier, CEO of Sangamo, spoke at the Stem Cells USA Regenerative Medicine Congress 2012 on the topic, #39;Engineering genetic cures: employing zinc finger nucleases (ZFNs) in stem cells. #39; The Stem Cells Regenerative Medicine Congress is where pharma, biotech, academia, government and investors come to uncover the technologies, strategies and business models that will help get stem cell and regenerative medicine treatments to market faster and more cost effectively. For more information, go to http://www.terrapinn.com/stemcellsusa. Or, check out our blog at blogs.terrapinn.com/total-biopharma for up to date information on the stem cells, RM and cord blood banking and therapeutics sectors.From:biopharmachannelViews:0 0ratingsTime:24:15More inScience Technology

Read the original post:
Edward Lanphier of Sangamo on engineering genetic cures - at Stem Cells USA

Teresa Leezer of Rhinocyte on neurodegenerative conditions - at Stem Cells USA RM Congress 2012
Teresa Leezer, COO of Rhinocyte, spoke at the Stem Cells USA Regenerative Medicine Congress 2012 on the topic, #39;Using autologous olfactory epithelial cells to treat neurodegenerative conditions. #39; The Stem Cells Regenerative Medicine Congress is where pharma, biotech, academia, government and investors come to uncover the technologies, strategies and business models that will help get stem cell and regenerative medicine treatments to market faster and more cost effectively. For more information, go to http://www.terrapinn.com/stemcellsusa. Or, check out our blog at blogs.terrapinn.com/total-biopharma for up to date information on the stem cells, RM and cord blood banking and therapeutics sectors.From:biopharmachannelViews:0 0ratingsTime:14:58More inScience Technology

The rest is here:
Teresa Leezer of Rhinocyte on neurodegenerative conditions - at Stem Cells USA

Michael West of BioTime on hES cell-based therapies - at Stem Cells USA RM Congress 2012
Michael West, CEO of BioTime, spoke at the Stem Cells USA Regenerative Medicine Congress 2012 on the topic, #39;Second generation hES cell-based therapies: achieving purity and scalability in the midst of diversity. #39; The Stem Cells Regenerative Medicine Congress is where pharma, biotech, academia, government and investors come to uncover the technologies, strategies and business models that will help get stem cell and regenerative medicine treatments to market faster and more cost effectively. For more information, go to http://www.terrapinn.com/stemcellsusa. Or, check out our blog at blogs.terrapinn.com/total-biopharma for up to date information on the stem cells, RM and cord blood banking and therapeutics sectors.From:biopharmachannelViews:0 0ratingsTime:23:31More inScience Technology

Here is the original post:
Michael West of BioTime on hES cell-based therapies - at Stem Cells USA

Ed Field of Cytomedix on biotech collaboration in RM - at Stem Cells USA RM Congress 2012
Ed Field, Chief Operating Officer of Cytomedix, spoke at the Stem Cells USA Regenerative Medicine Congress 2012 on the topic, #39;Biotech collaboration in RM: Cytomedix #39;s acquisition of Aldagen. #39; The Stem Cells Regenerative Medicine Congress is where pharma, biotech, academia, government and investors come to uncover the technologies, strategies and business models that will help get stem cell and regenerative medicine treatments to market faster and more cost effectively. For more information, go to http://www.terrapinn.com/stemcellsusa. Or, check out our blog at blogs.terrapinn.com/total-biopharma for up to date information on the stem cells, RM and cord blood banking and therapeutics sectors.From:biopharmachannelViews:0 0ratingsTime:24:03More inScience Technology

Original post:
Ed Field of Cytomedix on biotech collaboration in RM - at Stem Cells USA

Alternative funding sources for regenerative medicine - panel discussion at Stem Cells USA 2012
Stem Cells USA Regenerative Medicine Congress 2012 featured an exciting panel discussion on the topic, #39;Looking to alternative funding sources for the regenerative medicine field. #39; Panelists included: Ed Field, Chief Operating Officer, Cytomedix Dan Gincel, Director, Maryland Stem Cell Research Fund Elona Baum, General Counsel, California Institute for Regenerative Medicine (CIRM) Brock Reeve, Executive Director, Harvard Stem Cell Institute The Stem Cells Regenerative Medicine Congress is where pharma, biotech, academia, government and investors come to uncover the technologies, strategies and business models that will help get stem cell and regenerative medicine treatments to market faster and more cost effectively. For more information, go to http://www.terrapinn.com/stemcellsusa. Or, check out our blog at blogs.terrapinn.com/total-biopharma for up to date information on the stem cells, RM and cord blood banking and therapeutics sectors.From:biopharmachannelViews:0 0ratingsTime:50:04More inScience Technology

Visit link:
Alternative funding sources for regenerative medicine - panel discussion at Stem Cells USA 2012 - Video

Mathew Vincent of ACT on hESC derived RPE cells - at Stem Cells USA RM Congress 2012
Mathew Vincent, Director of Business Development at Advanced Cell Technology, spoke at the Stem Cells USA Regenerative Medicine Congress 2012 on the topic, #39;Meaningful clinical results with hESC derived RPE cells in patients with SMD and Dry AMD. #39; The Stem Cells Regenerative Medicine Congress is where pharma, biotech, academia, government and investors come to uncover the technologies, strategies and business models that will help get stem cell and regenerative medicine treatments to market faster and more cost effectively. For more information, go to http://www.terrapinn.com/stemcellsusa. Or, check out our blog at blogs.terrapinn.com/total-biopharma for up to date information on the stem cells, RM and cord blood banking and therapeutics sectors.From:biopharmachannelViews:0 1ratingsTime:25:03More inScience Technology

See the original post here:
Mathew Vincent of ACT on hESC derived RPE cells - at Stem Cells USA

Donna Skerrett of Mesoblast on adult stem cell therapies - at Stem Cells USA RM Congress 2012
Donna Skerrett, Chief Medical Officer of Mesoblast, presented a case study on Mesoblast and their adult stem cell therapy at the Stem Cells USA Regenerative Medicine Congress 2012. The Stem Cells Regenerative Medicine Congress is where pharma, biotech, academia, government and investors come to uncover the technologies, strategies and business models that will help get stem cell and regenerative medicine treatments to market faster and more cost effectively. For more information, go to http://www.terrapinn.com/stemcellsusa. Or, check out our blog at blogs.terrapinn.com/total-biopharma for up to date information on the stem cells, RM and cord blood banking and therapeutics sectors.From:biopharmachannelViews:0 0ratingsTime:21:30More inScience Technology

See the original post:
Donna Skerrett of Mesoblast on adult stem cell therapies - at Stem Cells USA